The Excelsior Solutions Difference

PBM Consulting

Substantially reducing pharmacy benefit costs without sacrificing plan quality.

Specialty Drug Management

Managing one of the largest hidden costs of medical care.

Medicare & Medicaid

Navigating a complex marketplace.

ABOUT US

Your cutting-edge expert with the resources to manage your pharmacy program effectively, contain cost, and be accountable for the results. We are the next generation; we are the solution.

Insights & Publications

Q2 2020 Excelsior Newsletter

The Rebate Bubble by Jonalan Smith, PharmD, FASCP, Senior Vice President Everyone knows the recent ‘bubbles’ that have impacted the economy in major way: The

Q1 2020 Excelsior Newsletter

The Impact Of Humira Citrate-Free by Bob Kordella, R.Ph., MBA Humira is typically in the top five drugs by spend for most plan sponsors. In

Q4 2019 Excelsior Newsletter

HIV PrEP Therapies by Darian Hurst, Vice President In June 2019, the United States Preventive Services Task Force (USPSTF) published a final recommendation that clinicians

Opioid Case Study

Opioid Case Study Annual Savings of  $192,000 Challenge Member filling pain

Humalog Lispro News

As you may recall, back in March of this year, Eli Lilly announced that they would begin to manufacture and sell an authorized generic version

Generic Advair Diskus Approved

The news that the FDA approved the first A-rated (meaning that pharmacists may freely substitute it without physician approval) generic form of Advair Diskus on

ICER Update 02.27.20

Hello, everyone, and welcome to this week’s edition of Excelsior Solutions’ ICER Update.Here is this week’s ICER recap: ICER released a Draft Evidence Report for

ICER Update 03.23.20

NOTE: Since today’s update was written, ICER has announced either the indefinite postponement (Sickle Cell Disease, Cystic Fibrosis) or 2 to 3 month delay (NASH,

ICER Update 01.29.20

Hello, everyone, and welcome to this week’s edition of Excelsior Solutions’ ICER Update. Here is this week’s ICER recap: ICER released a draft evidence report

Contact Us

Your Name (required)

Your Email (required)

Your Message

Please prove you are human by selecting the House.